LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article ; Online: Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study.

    Gibani, Malick M / Toumazou, Christofer / Sohbati, Mohammadreza / Sahoo, Rashmita / Karvela, Maria / Hon, Tsz-Kin / De Mateo, Sara / Burdett, Alison / Leung, K Y Felice / Barnett, Jake / Orbeladze, Arman / Luan, Song / Pournias, Stavros / Sun, Jiayang / Flower, Barney / Bedzo-Nutakor, Judith / Amran, Maisarah / Quinlan, Rachael / Skolimowska, Keira /
    Herrera, Carolina / Rowan, Aileen / Badhan, Anjna / Klaber, Robert / Davies, Gary / Muir, David / Randell, Paul / Crook, Derrick / Taylor, Graham P / Barclay, Wendy / Mughal, Nabeela / Moore, Luke S P / Jeffery, Katie / Cooke, Graham S

    The Lancet. Microbe

    2020  Volume 1, Issue 7, Page(s) e300–e307

    Abstract: Background: Access to rapid diagnosis is key to the control and management of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Laboratory RT-PCR testing is the current standard of care but usually requires a centralised laboratory and ... ...

    Abstract Background: Access to rapid diagnosis is key to the control and management of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Laboratory RT-PCR testing is the current standard of care but usually requires a centralised laboratory and significant infrastructure. We describe our diagnostic accuracy assessment of a novel, rapid point-of-care real time RT-PCR CovidNudge test, which requires no laboratory handling or sample pre-processing.
    Methods: Between April and May, 2020, we obtained two nasopharyngeal swab samples from individuals in three hospitals in London and Oxford (UK). Samples were collected from three groups: self-referred health-care workers with suspected COVID-19; patients attending emergency departments with suspected COVID-19; and hospital inpatient admissions with or without suspected COVID-19. For the CovidNudge test, nasopharyngeal swabs were inserted directly into a cartridge which contains all reagents and components required for RT-PCR reactions, including multiple technical replicates of seven SARS-CoV-2 gene targets (
    Findings: We obtained 386 paired samples: 280 (73%) from self-referred health-care workers, 15 (4%) from patients in the emergency department, and 91 (23%) hospital inpatient admissions. Of the 386 paired samples, 67 tested positive on the CovidNudge point-of-care platform and 71 with standard laboratory RT-PCR. The overall sensitivity of the point-of-care test compared with laboratory-based testing was 94% (95% CI 86-98) with an overall specificity of 100% (99-100). The sensitivity of the test varied by group (self-referred healthcare workers 94% [95% CI 85-98]; patients in the emergency department 100% [48-100]; and hospital inpatient admissions 100% [29-100]). Specificity was consistent between groups (self-referred health-care workers 100% [95% CI 98-100]; patients in the emergency department 100% [69-100]; and hospital inpatient admissions 100% [96-100]). Point of care testing performance was similar during a period of high background prevalence of laboratory positive tests (25% [95% 20-31] in April, 2020) and low prevalence (3% [95% 1-9] in inpatient screening). Amplification of viral nucleocapsid (n1, n2, and n3) and envelope protein gene (e-gene) were most sensitive for detection of spiked SARS-CoV-2 RNA.
    Interpretation: The CovidNudge platform was a sensitive, specific, and rapid point of care test for the presence of SARS-CoV-2 without laboratory handling or sample pre-processing. The device, which has been implemented in UK hospitals since May, 2020, could enable rapid decisions for clinical care and testing programmes.
    Funding: National Institute of Health Research (NIHR) Imperial Biomedical Research Centre, NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at Oxford University in partnership with Public Health England, NIHR Biomedical Research Centre Oxford, and DnaNudge.
    MeSH term(s) COVID-19/diagnosis ; Humans ; Point-of-Care Testing ; RNA, Viral/genetics ; SARS-CoV-2 ; Sensitivity and Specificity
    Chemical Substances RNA, Viral
    Keywords covid19
    Language English
    Publishing date 2020-09-17
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2666-5247
    ISSN (online) 2666-5247
    DOI 10.1016/S2666-5247(20)30121-X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: CovidNudge: diagnostic accuracy of a novel lab-free point-of-care diagnostic for SARS-CoV-2

    Gibani, Malick M / Toumazou, Christofer / Sohbati, Mohammadreza / Sahoo, Rashmita / Karvela, Maria / Hon, Tsz-Kin / Mateo, Sara De / Burdett, Alison / Leung, K Y Felice / Barnett, Jake / Orbeladze, Arman / Luan, Song / Pournias, Stavros / Sun, Jiayang / Flower, Barnaby / Bedzo-Nutakor, Judith / Amran, Maisarah / Quinlan, Rachael / Skolimowska, Keira /
    Klaber, Robert / Davies, Gary / Muir, David / Randell, Paul / Crook, Derrick W M / Taylor, Graham P / Barclay, Wendy / Mughal, Nabeela / Moore, Luke S P / Jeffery, Katie / Cooke, Graham S

    Abstract: Background Access to rapid diagnosis is key to the control and management of SARS-CoV-2. Reverse Transcriptase- Polymerase Chain Reaction (RT-PCR) testing usually requires a centralised laboratory and significant infrastructure. We describe the ... ...

    Abstract Background Access to rapid diagnosis is key to the control and management of SARS-CoV-2. Reverse Transcriptase- Polymerase Chain Reaction (RT-PCR) testing usually requires a centralised laboratory and significant infrastructure. We describe the development and diagnostic accuracy assessment of a novel, rapid point-of-care RT-PCR test, the DnaNudge platform CovidNudge test, which requires no laboratory handling or sample pre-processing. Methods Nasopharyngeal swabs are inserted directly into a cartridge which contains all reagents and components required for RT-PCR reactions, including multiple technical replicates of seven SARS-CoV-2 gene targets (rdrp1, rdrp2, e-gene, n-gene, n1, n2 and n3) and human ribonuclease P (RNaseP) as a positive control. Between April and May 2020, swab samples were tested in parallel using the CovidNudge direct-to-cartridge platform and standard laboratory RT-PCR using swabs in viral transport medium. Samples were collected from three groups: self-referred healthcare workers with suspected COVID-19 (Group 1, n=280/386; 73%); patients attending the emergency department with suspected COVID-19 (Group 2, n=15/386; 4%) and hospital inpatient admissions with or without suspected COVID-19 (Group 3, n=91/386; 23%). Results Of 386 paired samples tested across all groups, 67 tested positive on the CovidNudge platform and 71 with standard laboratory RT-PCR. The sensitivity of the test varied by group (Group 1 93% [84-98%], Group 2 100% [48-100%] and Group 3 100% [29-100%], giving an average sensitivity of 94.4% (95% confidence interval 86-98%) and an overall specificity of 100% (95%CI 99-100%; Group 1 100% [98-100%]; Group 2 100% [69-100%] and Group 3 100% [96-100%]). Point of care testing performance was comparable during a period of high (25%) and low (3%) background prevalence. Amplification of the viral nucleocapsid (n1, n2, n3) targets were most sensitive for detection of SARS-CoV2, with the assay able to detect 1x104 viral particles in a single swab. Conclusions The CovidNudge platform offers a sensitive, specific and rapid point of care test for the presence of SARS-CoV-2 without laboratory handling or sample pre-processing. The implementation of such a device could be used to enable rapid decisions for clinical care and testing programs.
    Keywords covid19
    Publisher MedRxiv; WHO
    Document type Article ; Online
    Note WHO #Covidence: #20174193
    DOI 10.1101/2020.08.13.20174193
    Database COVID19

    Kategorien

  3. Article ; Online: CovidNudge: diagnostic accuracy of a novel lab-free point-of-care diagnostic for SARS-CoV-2

    Gibani, Malick M / Toumazou, Christofer / Sohbati, Mohammadreza / Sahoo, Rashmita / Karvela, Maria / Hon, Tsz-Kin / De Mateo, Sara / Burdett, Alison / Leung, K Y Felice / Barnett, Jake / Orbeladze, Arman / Luan, Song / Pournias, Stavros / Sun, Jiayang / Flower, Barnaby / Bedzo-Nutakor, Judith / Amran, Maisarah / Quinlan, Rachael / Skolimowska, Keira /
    Klaber, Robert / Davies, Gary / Muir, David / Randell, Paul / Crook, Derrick W M / Taylor, Graham P / Barclay, Wendy / Mughal, Nabeela / Moore, Luke S P / Jeffery, Katie / Cooke, Graham S

    medRxiv

    Abstract: Background Access to rapid diagnosis is key to the control and management of SARS-CoV-2. Reverse Transcriptase- Polymerase Chain Reaction (RT-PCR) testing usually requires a centralised laboratory and significant infrastructure. We describe the ... ...

    Abstract Background Access to rapid diagnosis is key to the control and management of SARS-CoV-2. Reverse Transcriptase- Polymerase Chain Reaction (RT-PCR) testing usually requires a centralised laboratory and significant infrastructure. We describe the development and diagnostic accuracy assessment of a novel, rapid point-of-care RT-PCR test, the DnaNudge platform CovidNudge test, which requires no laboratory handling or sample pre-processing. Methods Nasopharyngeal swabs are inserted directly into a cartridge which contains all reagents and components required for RT-PCR reactions, including multiple technical replicates of seven SARS-CoV-2 gene targets (rdrp1, rdrp2, e-gene, n-gene, n1, n2 and n3) and human ribonuclease P (RNaseP) as a positive control. Between April and May 2020, swab samples were tested in parallel using the CovidNudge direct-to-cartridge platform and standard laboratory RT-PCR using swabs in viral transport medium. Samples were collected from three groups: self-referred healthcare workers with suspected COVID-19 (Group 1, n=280/386; 73%); patients attending the emergency department with suspected COVID-19 (Group 2, n=15/386; 4%) and hospital inpatient admissions with or without suspected COVID-19 (Group 3, n=91/386; 23%). Results Of 386 paired samples tested across all groups, 67 tested positive on the CovidNudge platform and 71 with standard laboratory RT-PCR. The sensitivity of the test varied by group (Group 1 93% [84-98%], Group 2 100% [48-100%] and Group 3 100% [29-100%], giving an average sensitivity of 94.4% (95% confidence interval 86-98%) and an overall specificity of 100% (95%CI 99-100%; Group 1 100% [98-100%]; Group 2 100% [69-100%] and Group 3 100% [96-100%]). Point of care testing performance was comparable during a period of high (25%) and low (3%) background prevalence. Amplification of the viral nucleocapsid (n1, n2, n3) targets were most sensitive for detection of SARS-CoV2, with the assay able to detect 1x104 viral particles in a single swab. Conclusions The CovidNudge platform offers a sensitive, specific and rapid point of care test for the presence of SARS-CoV-2 without laboratory handling or sample pre-processing. The implementation of such a device could be used to enable rapid decisions for clinical care and testing programs.
    Keywords covid19
    Language English
    Publishing date 2020-08-15
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2020.08.13.20174193
    Database COVID19

    Kategorien

  4. Article: Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study

    Gibani, Malick M / Toumazou, Christofer / Sohbati, Mohammadreza / Sahoo, Rashmita / Karvela, Maria / Hon, Tsz-Kin / De Mateo, Sara / Burdett, Alison / Leung, K Y Felice / Barnett, Jake / Orbeladze, Arman / Luan, Song / Pournias, Stavros / Sun, Jiayang / Flower, Barney / Bedzo-Nutakor, Judith / Amran, Maisarah / Quinlan, Rachael / Skolimowska, Keira /
    Herrera, Carolina / Rowan, Aileen / Badhan, Anjna / Klaber, Robert / Davies, Gary / Muir, David / Randell, Paul / Crook, Derrick / Taylor, Graham P / Barclay, Wendy / Mughal, Nabeela / Moore, Luke S P / Jeffery, Katie / Cooke, Graham S

    Abstract: Background: Access to rapid diagnosis is key to the control and management of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Laboratory RT-PCR testing is the current standard of care but usually requires a centralised laboratory and ... ...

    Abstract Background: Access to rapid diagnosis is key to the control and management of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Laboratory RT-PCR testing is the current standard of care but usually requires a centralised laboratory and significant infrastructure. We describe our diagnostic accuracy assessment of a novel, rapid point-of-care real time RT-PCR CovidNudge test, which requires no laboratory handling or sample pre-processing. Methods: Between April and May, 2020, we obtained two nasopharyngeal swab samples from individuals in three hospitals in London and Oxford (UK). Samples were collected from three groups: self-referred health-care workers with suspected COVID-19; patients attending emergency departments with suspected COVID-19; and hospital inpatient admissions with or without suspected COVID-19. For the CovidNudge test, nasopharyngeal swabs were inserted directly into a cartridge which contains all reagents and components required for RT-PCR reactions, including multiple technical replicates of seven SARS-CoV-2 gene targets (rdrp1, rdrp2, e-gene, n-gene, n1, n2 and n3) and human ribonuclease P (RNaseP) as sample adequacy control. Swab samples were tested in parallel using the CovidNudge platform, and with standard laboratory RT-PCR using swabs in viral transport medium for processing in a central laboratory. The primary analysis was to compare the sensitivity and specificity of the point-of-care CovidNudge test with laboratory-based testing. Findings: We obtained 386 paired samples: 280 (73%) from self-referred health-care workers, 15 (4%) from patients in the emergency department, and 91 (23%) hospital inpatient admissions. Of the 386 paired samples, 67 tested positive on the CovidNudge point-of-care platform and 71 with standard laboratory RT-PCR. The overall sensitivity of the point-of-care test compared with laboratory-based testing was 94% (95% CI 86-98) with an overall specificity of 100% (99-100). The sensitivity of the test varied by group (self-referred healthcare workers 93% [95% CI 84-98]; patients in the emergency department 100% [48-100]; and hospital inpatient admissions 100% [29-100]). Specificity was consistent between groups (self-referred health-care workers 100% [95% CI 98-100%]; patients in the emergency department 100% [69-100]; and hospital inpatient admissions 100% [96-100]). Point of care testing performance was similar during a period of high background prevalence of laboratory positive tests (25% [95% 20-31] in April, 2020) and low prevalence (3% [95% 1-9] in inpatient screening). Amplification of viral nucleocapsid (n1, n2, and n3) and envelope protein gene (e-gene) were most sensitive for detection of spiked SARS-CoV-2 RNA. Interpretation: The CovidNudge platform was a sensitive, specific, and rapid point of care test for the presence of SARS-CoV-2 without laboratory handling or sample pre-processing. The device, which has been implemented in UK hospitals since May, 2020, could enable rapid decisions for clinical care and testing programmes. Funding: National Institute of Health Research (NIHR) Imperial Biomedical Research Centre, NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at Oxford University in partnership with Public Health England, NIHR Biomedical Research Centre Oxford, and DnaNudge.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #786465
    Database COVID19

    Kategorien

  5. Article ; Online: Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge)

    Gibani, Malick M / Toumazou, Christofer / Sohbati, Mohammadreza / Sahoo, Rashmita / Karvela, Maria / Hon, Tsz-Kin / De Mateo, Sara / Burdett, Alison / Leung, K Y Felice / Barnett, Jake / Orbeladze, Arman / Luan, Song / Pournias, Stavros / Sun, Jiayang / Flower, Barney / Bedzo-Nutakor, Judith / Amran, Maisarah / Quinlan, Rachael / Skolimowska, Keira /
    Herrera, Carolina / Rowan, Aileen / Badhan, Anjna / Klaber, Robert / Davies, Gary / Muir, David / Randell, Paul / Crook, Derrick / Taylor, Graham P / Barclay, Wendy / Mughal, Nabeela / Moore, Luke S P / Jeffery, Katie / Cooke, Graham S

    The Lancet Microbe

    a diagnostic accuracy study

    2020  Volume 1, Issue 7, Page(s) e300–e307

    Keywords covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ISSN 2666-5247
    DOI 10.1016/s2666-5247(20)30121-x
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top